A study of the four different routes of administration of sumatriptan shows that the way the drug is given can impact how quickly and effectively a patient will receive migraine relief. In this review ...

What is sumatriptan used for? Sumatriptan is commonly used for the treatment of migraine with or without aura. An aura may occur before or during a migraine attack, and can include sensory problems ...

Sumatriptan oral tablet is a prescription drug that’s available as the brand-name drug Imitrex. It’s also available as a generic drug. Generic drugs usually cost less. In some cases, they may not be ...

Sumatriptan is a generic prescription drug used to treat migraine and cluster headaches in adults. It’s available in three forms: a tablet that you swallow nasal (nose) spray a liquid solution that’s ...

Sumavel(TM) DosePro(TM) (sumatriptan injection) Approved by FDA for Acute Migraine and Cluster Headache: First Product Featuring Novel DosePro Needle-Free Delivery System SAN DIEGO, July 16 ...

Sumatriptan 5mg, 20mg; per spray. The vascular 5-HT 1 receptor subtype to which sumatriptan binds selectively, and through which it presumably exerts its antimigrainous effect, is present on cranial ...

Washington, DC — Sumatriptan is less effective in migraine attacks with aura than in those without, new data reveal. The findings, from an analysis of previous clinical trial results, were presented ...

Drug major Cipla on Tuesday said it has received final approval from the United States Food and Drug Administration (USFDA) for Sumatriptan Nasal Spray, indicated for the treatment of migraine attacks ...

Tosymra Nasal Spray 10 mg is a Proprietary Acute Migraine Treatment Approved Under the 505(b)2 Pathway Based on Bioequivalence to Imitrex (sumatriptan) Injection 4 mg GlaxoSmithKline Recently Notified ...

“With the approval and launch of sumatriptan injection, we remain optimistic on progress of our other combination product development programs with Teva, which are currently under FDA review.” ...

Topical morphine 0.5% significantly reduced pain, caused no complications and did not impede corneal healing after PRK, according to a team of researchers in California. Now, the investigators are ...